Masayuki Takano

Masayuki Takano

Auto-generated profile, based on publicly available information

Masayuki Takano

Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
MTMasayuki Takano
Masayuki Takano
HKHidekazu Kondo
Hidekazu Kondo
THTaisuke Harada
Taisuke Harada
MTMasaki Takahashi
Masaki Takahashi
YIYumi Ishii
Yumi Ishii
NTNaohiko Takahashi
Naohiko Takahashi
• SGLT2 is primarily expressed in human preadipocytes in the epicardial adipose tissue. • The expression levels of SGLT2 diminish as the preadipocytes are differentiated to mature adipocytes. • The SGLT2 inhibitor empagliflozin improves the paracrine secretome profiles, potentially leading to the cardioprotective effect. • IL6 may be a critical adipokine that is regulated by SGLT2 inhibitors.

3 July 2025 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
THTaisuke Harada
Taisuke Harada
HKHidekazu Kondo
Hidekazu Kondo
MTMasaki Takahashi
Masaki Takahashi
HYHirochika Yamasaki
Hirochika Yamasaki
MTMasayuki Takano
Masayuki Takano
NTNaohiko Takahashi
Naohiko Takahashi